Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2
Public DepositedAdd to collection
You do not have access to any existing collections. You may create a new collection.
Downloadable Content
Download PDFCitation
MLA
Walls, A.C, et al. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for Sars-cov-2. Cell Press, 2020. https://doi.org/10.17615/tgyh-m598APA
Walls, A., Fiala, B., Schäfer, A., Wrenn, S., Pham, M., Murphy, M., Tse, L., Shehata, L., O&Apos;Connor, M., Chen, C., Navarro, M., Miranda, M., Pettie, D., Ravichandran, R., Kraft, J., Ogohara, C., Palser, A., Chalk, S., Lee, E., Guerriero, K., Kepl, E., Chow, C., Sydeman, C., Hodge, E., Brown, B., Fuller, J., Dinnon, K., Gralinski, L., Leist, S., Gully, K., Lewis, T., Guttman, M., Chu, H., Lee, K., Fuller, D., Baric, R., Kellam, P., Carter, L., Pepper, M., Sheahan, T., Veesler, D., & King, N. (2020). Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for SARS-CoV-2. Cell Press. https://doi.org/10.17615/tgyh-m598Chicago
Walls, A.C., B Fiala, A Schäfer, S Wrenn, M.N Pham, M Murphy, L.V Tse et al. 2020. Elicitation of Potent Neutralizing Antibody Responses by Designed Protein Nanoparticle Vaccines for Sars-Cov-2. Cell Press. https://doi.org/10.17615/tgyh-m598- Creator
-
Walls, A.C.
- Other Affiliation: University of Washington
-
Fiala, B.
- Other Affiliation: University of Washington
-
Schäfer, A.
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
-
Wrenn, S.
- Other Affiliation: University of Washington
-
Pham, M.N.
- Other Affiliation: University of Washington
-
Murphy, M.
- Other Affiliation: University of Washington
-
Tse, L.V.
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
-
Shehata, L.
- Other Affiliation: University of Washington
-
O'Connor, M.A.
- Other Affiliation: University of Washington
-
Chen, C.
- Other Affiliation: University of Washington
-
Navarro, M.J.
- Other Affiliation: University of Washington
-
Miranda, M.C.
- Other Affiliation: University of Washington
-
Pettie, D.
- Other Affiliation: University of Washington
-
Ravichandran, R.
- Other Affiliation: University of Washington
-
Kraft, J.C.
- Other Affiliation: University of Washington
-
Ogohara, C.
- Other Affiliation: University of Washington
-
Palser, A.
- Other Affiliation: Kymab Ltd.
-
Chalk, S.
- Other Affiliation: Kymab Ltd.
-
Lee, E.-C.
- Other Affiliation: Kymab Ltd.
-
Guerriero, K.
- Other Affiliation: University of Washington
-
Kepl, E.
- Other Affiliation: University of Washington
-
Chow, C.M.
- Other Affiliation: University of Washington
-
Sydeman, C.
- Other Affiliation: University of Washington
-
Hodge, E.A.
- Other Affiliation: University of Washington
-
Brown, B.
- Other Affiliation: University of Washington
-
Fuller, J.T.
- Other Affiliation: University of Washington
-
Dinnon, III, K.H.
- Affiliation: School of Medicine, Department of Microbiology and Immunology
-
Gralinski, L.E.
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
-
Leist, S.R.
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
-
Gully, K.L.
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
-
Lewis, T.B.
- Other Affiliation: University of Washington
-
Guttman, M.
- Other Affiliation: University of Washington
-
Chu, H.Y.
- Other Affiliation: University of Washington
-
Lee, K.K.
- Other Affiliation: University of Washington
-
Fuller, D.H.
- Other Affiliation: University of Washington
-
Baric, R.S.
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
-
Kellam, P.
- Other Affiliation: Kymab Ltd.
-
Carter, L.
- Other Affiliation: University of Washington
-
Pepper, M.
- Other Affiliation: University of Washington
-
Sheahan, T.P.
- Affiliation: Gillings School of Global Public Health, Department of Epidemiology
-
Veesler, D.
- Other Affiliation: University of Washington
-
King, N.P.
- Other Affiliation: University of Washington
- Abstract
- Walls et al. describe a potential nanoparticle vaccine for COVID-19, made of a self-assembling protein nanoparticle displaying the SARS-CoV-2 receptor-binding domain in a highly immunogenic array reminiscent of the natural virus. Their nanoparticle vaccine candidate elicits a diverse, potent, and protective antibody response, including neutralizing antibody titers 10-fold higher than the prefusion-stabilized spike ectodomain trimer.
- Date of publication
- 2020
- Keyword
- DOI
- Identifier
- https://dx.doi.org/10.1016/j.cell.2020.10.043
- PMID 33160446
- Resource type
- Article
- Rights statement
- In Copyright
- License
- Attribution 3.0 United States
- Journal title
- Cell
- Journal volume
- 183
- Journal issue
- 5
- Page start
- 1367
- Page end
- 1.38E+20
- Language
- English
- Version
- Publisher
- ISSN
- 0092-8674
- Publisher
- Cell Press
Relations
- Parents:
- In Collection:
This work has no parents.
Items
Thumbnail | Title | Date Uploaded | Visibility | Actions |
---|---|---|---|---|
1-s2.0-S0092867420314501-main.pdf | 2021-01-04 | Public | Download |